source
- Amgen to open new R&D Science and Innovation Center in Hyderabad's Genome Valley by 2027Amgen announced plans to establish a Science and Innovation Center in Hyderabad's Genome Valley, a biotech hub in India. The facility is slated to open in 2027 and will become part of Amgen's globa…
- FDA rejects ITM Isotope's radiopharmaceutical therapy over manufacturing problems, halting potential competitor to NovartisThe U.S. Food and Drug Administration has refused to approve a radiopharmaceutical therapy developed by ITM Isotope Technologies Munich SE, citing manufacturing deficiencies. The therapy was desig…